2013 Immunology of Fungal Infections GRC and GRS
2013 Immunology of Fungal Infections GRC and GRS
批准号:
8451034
负责人:
Stuart Michael Levitz
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-11 至 2013-12-31
关键词:
Acquired Immunodeficiency SyndromeAddressAntifungal AgentsAreaAspergillusBasic ScienceCandidaCollaborationsCommunitiesCryptococcusDataDevelopmentDisabled PersonsDiseaseEnvironmentFosteringGenderGoalsHealthImmuneImmune responseImmunityImmunologic Deficiency SyndromesImmunologyImmunotherapeutic agentImmunotherapyInfectionInternationalMedicalMinority GroupsMycosesOperative Surgical ProceduresOralParticipantPersonsPopulationPredispositionRequest for ProposalsResearchResearch PersonnelStructureStudentsTexasTimeTrainingTranslational ResearchVaccinationWorkabstractingfungusimmunoregulationinsightmeetingsmembermortalityneglectnext generationnovel strategiespandemic diseaseparitypathogenposterspreventprogramspublic health relevancesuccesssymposium
中文摘要
描述(由申请人提供):本提案要求部分支持将于2013年1月12日至18日在德克萨斯州加尔维斯顿举行的戈登研究会议(GRC)和戈登研究研讨会(GRS)中的真菌感染免疫学会议。本次会议的广泛和长期目标是汇集世界领先的研究人员在这个迅速扩大的领域,以促进跨学科的讨论和合作,以提高我们对抗真菌免疫的理解,旨在开发新的见解来控制这些病原体。2011年1月举行的首届GRC取得了巨大的成功,本次会议将首次包括与GRC联合举行的GRS。
本次会议的具体目标将是召集40多位领先的专家,他们将介绍大部分未发表的数据和见解,涵盖真菌免疫学领域的关键领域。我们预计在一个相对孤立的环境中举行为期五天的会议,与会者总数超过150人。GRC计划将分为九个部分,全面涵盖决定先天性和适应性免疫反应的各种宿主和真菌因素。基础研究和翻译研究都将受到重视。下午的海报讨论会将使所有与会者都能对这些专题作出贡献,由会议主席和副主席挑选最有价值的摘要进行口头介绍。将尽一切努力鼓励研究生和博士后学者参加研究中心。此外,将在GRC之前举行的GRS将专门针对学员,使他们能够在轻松和额外支持的环境中展示他们的研究并进行互动。将尽一切努力实现两性平等,并将少数种族/族裔和残疾人包括在内。该应用程序的意义在于,该GRC和GRS将提供一个论坛,将致力于真菌感染免疫学的国际研究界成员聚集在一起并发挥协同作用。GRS将具有帮助培训和激励该领域下一代研究人员的附加价值。该应用程序与健康的相关性在于,所产生的讨论将有助于定义与基础科学相关的重要问题以及开发免疫治疗新策略所需的问题。迫切需要后者,以降低与这些破坏性疾病的系统性形式相关的极高死亡率。
英文摘要
DESCRIPTION (provided by applicant): This proposal requests partial support for a meeting on the Immunology of Fungal Infections as part of a Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) to be held in Galveston, Texas, January 12-18, 2013. The broad and long-term goal of this conference is to bring together the world's leading researchers in this rapidly expanding field to foster cross-disciplinary discussions and collaborations, so as to enhance our understanding of anti-fungal immunity with the aim of developing new insights for controlling these pathogens. The inaugural GRC held in January, 2011 was a great success and this conference will include, for the first time, a GRS to be held in conjunction with the GRC.
The specific aims of this meeting will be to convene over 40 leading experts who will present mostly unpublished data and insights covering critical areas within the field of fungal immunology. We expect a total of >150 participants for a five-day conference in a relatively isolated setting. The GRC program will be structured into nine sessions that comprehensively cover the various host and fungal factors that determine innate and adaptive immune responses. Both basic and translation research will be emphasized. Afternoon poster sessions will permit all participants to contribute to these topics with the most meritorious abstracts chosen by the conference Chairs and Vice-Chairs for oral presentation. Every effort will be made to encourage participation by postgraduate students and postdoctoral scholars in the GRC. In addition, the GRS, which will take place immediately preceding the GRC, will be specifically aimed at trainees, allowing them to present their research and interact in a relaxing and extra supportive environment. Every effort will be made to have gender parity and to include racial/ethnic minorities and persons with disabilities. The significance of this application is tha this GRC and GRS will provide a forum for bringing together and synergizing members of the international research community working on the immunology of fungal infections. The GRS will have the added value of helping to train and energize the next generation of researchers in the field. The health relatedness of this application is that the discussions generated will help defin the important questions relating to basic science as well as those required for the development of novel strategies for immunotherapy. The latter is desperately required so as to reduce the very high levels of mortality associated with systemic forms of these devastating diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A subunit Cryptococcus vaccine
-
批准号:10539210
-
项目类别:
-
资助金额:$61.98万
-
财政年份:2022
-
负责人:Stuart Michael Levitz
-
依托单位:
A subunit Cryptococcus vaccine
-
批准号:10669795
-
项目类别:
-
资助金额:$61.98万
-
财政年份:2022
-
负责人:Stuart Michael Levitz
-
依托单位:
The contribution of eosinophils and the IL-23/IL-17 axis to host responses to Aspergillus
-
批准号:10163121
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:10259153
-
项目类别:
-
资助金额:$79.9万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:10557083
-
项目类别:
-
资助金额:$79.31万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:10598929
-
项目类别:
-
资助金额:$75.38万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:9140479
-
项目类别:
-
资助金额:$65.75万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Preclinical studies of a Cryptococcus vaccine for AIDS patients
-
批准号:9222705
-
项目类别:
-
资助金额:$64.43万
-
财政年份:2016
-
负责人:Stuart Michael Levitz
-
依托单位:
Immune Response to Cryptococcal Infections
-
批准号:8963535
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2015
-
负责人:Stuart Michael Levitz
-
依托单位:
Immune Response to Cryptococcal Infections
-
批准号:9264958
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2015
-
负责人:Stuart Michael Levitz
-
依托单位:
Interactions of pDCs with Aspergilus
-
批准号:8605547
-
项目类别:
-
资助金额:$40.83万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Glucan Particles as a Vaccine Platform for Protective Immunity
-
批准号:8537625
-
项目类别:
-
资助金额:$52.45万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Glucan Particles as a Vaccine Platform for Protective Immunity
-
批准号:8890767
-
项目类别:
-
资助金额:$54.16万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Glucan Particles as a Vaccine Platform for Protective Immunity
-
批准号:8715685
-
项目类别:
-
资助金额:$54.22万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Interactions of pDCs with Aspergilus
-
批准号:8789386
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
Interactions of pDCs with Aspergilus
-
批准号:8463798
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Stuart Michael Levitz
-
依托单位:
2011 Immunology of Fungal Infections Gordon Research Conference
-
批准号:8057722
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2011
-
负责人:Stuart Michael Levitz
-
依托单位:
Immunostimulatory properties of chitin and chitosan
-
批准号:8320083
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2011
-
负责人:Stuart Michael Levitz
-
依托单位:
Immunostimulatory properties of chitin and chitosan
-
批准号:8071667
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2011
-
负责人:Stuart Michael Levitz
-
依托单位:
Model Vaccines Exploiting Fungal Mannosylation
-
批准号:7082067
-
项目类别:
-
资助金额:$8.77万
-
财政年份:2005
-
负责人:Stuart Michael Levitz
-
依托单位:
海外基金